These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32407801)

  • 1. Sputum Cell-Free DNA: Valued Surrogate Sample for Detection of EGFR Mutation in Patients with Advanced Lung Adenocarcinoma.
    Wang Z; Zhang L; Li L; Li X; Xu Y; Wang M; Liang L; Jiao P; Li Y; He S; Du J; He L; Tang M; Sun M; Yang L; Di J; Zhu G; Shi H; Liu D
    J Mol Diagn; 2020 Jul; 22(7):934-942. PubMed ID: 32407801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum cell-free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.
    Wang Z; Li X; Zhang L; Xu Y; Wang M; Liang L; Jiao P; Li Y; He S; Du J; He L; Tang M; Sun M; Yang L; Di J; Zhu G; Li L; Liu D
    Cancer Med; 2021 May; 10(10):3323-3331. PubMed ID: 33932095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR.
    Isaka T; Yokose T; Ito H; Nakayama H; Miyagi Y; Saito H; Masuda M
    BMC Pulm Med; 2021 Mar; 21(1):100. PubMed ID: 33757469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
    Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer.
    Thakur S; Rathor A; Jain S; Nambirajan A; Khurana S; Malik PS; Jain D
    J Am Soc Cytopathol; 2024; 13(4):291-302. PubMed ID: 38704351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.
    Wang Z; Li L; Wang Y; Li X; Xu Y; Wang M; Liang L; Wu X; Tang M; Li Y; He S; Du J; He L; Sun M; Yang L; Di J; Gai F; Liu D
    Cancer Cytopathol; 2023 Feb; 131(2):110-116. PubMed ID: 36103360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
    Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
    Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
    Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
    Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis].
    Su F; Zheng K; Fu Y; Wu Q; Tang Y; Wang W; Jiang L
    Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):389-396. PubMed ID: 29764589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.
    Wu YL; Sequist LV; Hu CP; Feng J; Lu S; Huang Y; Li W; Hou M; Schuler M; Mok T; Yamamoto N; O'Byrne K; Hirsh V; Gibson N; Massey D; Kim M; Yang JC
    Br J Cancer; 2017 Jan; 116(2):175-185. PubMed ID: 28006816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients.
    Kawahara A; Fukumitsu C; Azuma K; Taira T; Abe H; Takase Y; Murata K; Sadashima E; Hattori S; Naito Y; Akiba J
    Cytopathology; 2018 Apr; 29(2):150-155. PubMed ID: 29363841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell-free DNA of Patients With Lung Adenocarcinoma.
    Cui S; Ye L; Wang H; Chu T; Zhao Y; Gu A; Xiong L; Shi C; Jiang L
    Clin Lung Cancer; 2018 May; 19(3):e313-e322. PubMed ID: 29329944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens.
    Liu J; Zhao R; Zhang J; Zhang J
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):221-7. PubMed ID: 25156817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation detection in early-stage non-small-cell lung cancer.
    Wan Y; Liu B; Lei H; Zhang B; Wang Y; Huang H; Chen S; Feng Y; Zhu L; Gu Y; Zhang Q; Ma H; Zheng SY
    Ann Oncol; 2018 Dec; 29(12):2379-2383. PubMed ID: 30339193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.
    Arriola E; Paredes-Lario A; García-Gomez R; Diz-Tain P; Constenla M; García-Girón C; Márquez G; Reck M; López-Vivanco G
    Clin Transl Oncol; 2018 Oct; 20(10):1261-1267. PubMed ID: 29623586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR.
    Zhang Y; Xu Y; Zhong W; Zhao J; Chen M; Zhang L; Li L; Wang M
    Oncotarget; 2017 Jan; 8(4):5861-5873. PubMed ID: 28052016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening system for epidermal growth factor receptor mutation detection in cytology cell-free DNA of cerebrospinal fluid based on assured sample quality.
    Kawahara A; Abe H; Murata K; Ishii H; Azuma K; Takase Y; Hattori S; Naito Y; Akiba J
    Cytopathology; 2019 Mar; 30(2):144-149. PubMed ID: 30471155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
    Buder A; Setinek U; Hochmair MJ; Schwab S; Kirchbacher K; Keck A; Burghuber OC; Pirker R; Filipits M
    Target Oncol; 2019 Apr; 14(2):197-203. PubMed ID: 30810887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency EGFR genotyping using cell-free DNA in bronchial washing fluid.
    Murata Y; Nakajima Y; Sato Y; Hizawa N; Yamakawa D; Matsubara D; Noguchi M; Minami Y
    Jpn J Clin Oncol; 2024 Jun; 54(6):681-688. PubMed ID: 38476004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.